Alcidion GroupASX:ALC +1.05% Altman Z-Score is 2.73 as of Jun. 26, 2026, which is 38% below its 10-year median of 4.43. The stock has 4 warning signs investors should review. Among 662 Healthcare Providers & Services companies, Alcidion Group ranks better than 56.8% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Warning Sign:
Altman Z-score of 2.82 is in the grey area. This implies that the company is under some kind of financial stress. If it is below 1.8, the company may face bankruptcy risk.
Alcidion Group has a Altman Z-Score of 2.73, indicating it is in Grey Zones. This implies that Alcidion Group is in some kind of financial stress. If it is below 1.81, the company may face bankrupcy risk.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Alcidion Group's Altman Z-Score or its related term are showing as below:
ASX:ALC'
s Altman Z-Score Range Over the Past 10 Years
Min: 1.11 Med: 4.43 Max: 19.53
Current: 2.82
During the past 13 years, Alcidion Group's highest Altman Z-Score was 19.53. The lowest was 1.11. And the median was 4.43.
Alcidion Group (ASX:ALC) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
Alcidion Group Altman Z-Score Related Terms
Alcidion Group Altman Z-Score Historical Data
* Premium members only.
The historical data trend for Alcidion Group's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:ALC vs VEEV, BTSG, TEM: Altman Z-Score Comparison
For the Health Information Services subindustry, Alcidion Group's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alcidion Group Altman Z-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alcidion Group's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Alcidion Group's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
Alcidion Group's Altman Z-Score for today is calculated with this formula:
Z
=
1.2
*
X1
+
1.4
*
X2
+
3.3
*
X3
+
0.6
*
X4
+
1.0
*
X5
=
1.2
*
0.0244
+
1.4
*
-0.2453
+
3.3
*
0.0035
+
0.6
*
4.5872
+
1.0
*
0.2797
=
2.73
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Alcidion Group (ASX:ALC) has a Altman Z-Score of 2.73 as of Jun. 26, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Alcidion Group and its competitors. This is 38% below median its historical median of 4.43. Over the past decade, Alcidion Group's Altman Z-Score has ranged from 1.11 to 19.53. According to the industry distribution chart, Alcidion Group ranks #286 out of 662 companies in the Healthcare Providers & Services industry, placing it in the top 43.2%.
Is Alcidion Group's Altman Z-Score too high?
Alcidion Group's current Altman Z-Score of 2.73 is 38% below median its 10-year median of 4.43. Over the past 10 years, this metric has ranged from a low of 1.11 to a high of 19.53. The Healthcare Providers & Services industry median Altman Z-Score is 2.36. Alcidion Group's value of 2.73 is 15.7% above this industry median. Based on the distribution chart, Alcidion Group ranks #286 out of 662 companies in the Healthcare Providers & Services industry, which is above the industry midpoint.
How does Alcidion Group's Altman Z-Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Alcidion Group ranks #286 out of 662 companies for Altman Z-Score. This puts Alcidion Group in the upper half of its industry. The industry median Altman Z-Score is 2.36. Alcidion Group's value of 2.73 is 15.7% above this benchmark. Historically, Alcidion Group's own Altman Z-Score has ranged from 1.11 to 19.53 over the past decade. While the company's 10-year median is 4.43 vs. the industry median of 2.36, Alcidion Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Healthcare Providers & Services company?
The median Altman Z-Score among Healthcare Providers & Services companies is 2.36, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alcidion Group's current Altman Z-Score of 2.73 is 15.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Alcidion Group and its competitors. For the Healthcare Providers & Services industry, the median Altman Z-Score is 2.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcidion Group's current Altman Z-Score is 2.73, which is 38% below median its own 10-year median of 4.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcidion Group stock overvalued right now?
Based on GuruFocus' analysis, Alcidion Group (ASX:ALC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.12, compared to a current price of A$0.10 — trading 20% below its estimated fair value. The current Altman Z-Score is 2.73, which is 38% below median its 10-year median of 4.43 and 15.7% above the Healthcare Providers & Services industry median of 2.36. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Alcidion Group (ASX:ALC), the current Altman Z-Score is 2.73 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alcidion Group Ltd is a provider of intelligent informatics software. It offers a fully integrated digital patient care platform that includes a clinical decision support (CDS) system, Electronic Patient Record (EPR), and Patient Administration System (PAS). Alcidion is engaged in the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of healthcare software products from its strategic partners, and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in the United Kingdom, Australia, and New Zealand. The company generates maximum revenue from the United Kingdom.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ALC has been successfully added to your 